vialroom

#retatrutide 2025-06-29

Sunday22 messages5 participantstimes are UTC
Highlights from this day
  • fasting_insulin — anyone compared their Medutest purity across two different ERP lots 17:13
  • fasting_insulin — is there any long term safety data at all or is it phase 2 and hope 17:19
  • fibre_first — does the energy expenditure claim show up as anything you can feel 18:44
SS

unrelated but sat at 2.5 for 9 months rather than climbing and it kept working, so i never went up

SS

genuine question phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan

research use only

🙏8
SS

buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

SS

i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps

FI

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

is there any long term safety data at all or is it phase 2 and hope

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)

cant feel it honestly

AF

held at 15 for 16 months and it never plateaued for me, which i cant explain

watching my heart rate

settled by month three

🧪1🔥12
FF

does the energy expenditure claim show up as anything you can feel

[edited]
Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.

triple agonist yeah

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
👀8🧪13📉1